Plain-English translation of NCT06731218 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing , a treatment that involves transplanting insulin-producing cells (called islet cells) into people with type 1 diabetes. The goal is to see whether this treatment is safe and whether it can help reduce dangerous episodes of very low blood sugar. Researchers will carefully monitor participants to understand how well the medication works and what side effects, if any, might occur.
People with type 1 diabetes often struggle with unpredictable episodes of dangerously low blood sugar that can be life-threatening. Currently available treatments don't always prevent these episodes, so researchers are exploring whether transplanting healthy insulin-producing cells might offer a better way to control blood sugar and improve quality of life.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo a surgical procedure to have insulin-producing cells transplanted under the abdominal muscle. The trial will involve visits to the clinic so researchers can monitor your blood sugar levels, overall health, and any side effects over time. The exact length of follow-up and number of visits will be explained to you before you decide to participate.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China